CTI BIOPHARMA CORP: capex

Value{"amount": 1657000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2013-01-01 – 2013-12-31
Statuscurrent
EntityCTI BIOPHARMA CORP
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-14-082598 · Open the official SEC filing →
Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000891293/capex/2013-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/0a0aee1e-ebd9-438c-822b-65cf1f19ed32

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies